Replies to post #4639 on Phio Pharmaceuticals Corp (PHIO)

[$treet $inatra]

nice SM! $RXII +30% with multiple presentations coming in May:

This meeting is being held May 16-19, 2018 at Rosen Shingle Creek Resort in Orlando, Florida.

RXI-109 Treatment to Reduce the Formation of Hypertrophic Dermal Scars
RXI-109: sd-rxRNA targeting connective tissue growth factor (CTGF)
Date and Time: Thursday, May 17, 2018, 11:45 am – 1:45 p.m.
Session: Clinical Research, Pathophysiology and Therapeutics
Poster #: 496, Gatlin Ballroom

Samcyprone™ (diphenylcyclopropenone ointment) for the Treatment of Common Warts
Samcyprone: small molecule, proprietary topical formulation of diphenylcyclopropenone (DPCP)
Date and Time: Friday, May 18, 2018, 12:00 pm – 2:00 p.m.
Session: Clinical Research, Pathophysiology and Therapeutics
Poster #: 490, Gatlin Ballroom

Topical Administration of self-delivering RNAi (sd-rxRNA) Compounds for the Reduction of Hyperpigmentation
RXI-231: sd-rxRNA targeting tyrosinase (TYR)
Date and Time: Friday, May 18, 2018, 12:00 pm – 2:00 p.m.
Session: Pigmentation and Melanoma
Poster #: 1257, Gatlin Ballroom